Dr. Robert Whitfield explains that finding 10-HOME, an oxylipin, in implant tissue doesn't diagnose Breast Implant Illness. Higher levels appear in symptomatic patients, but that's association, not proof of cause. He warns against treating it as a validated diagnostic marker.
Does finding tinhome mean that someone has breast implant illness? No, not necessarily. Tinhome is an oxylipin, which is an oxygenated lipid molecule. Researchers found higher levels of it in implant-associated tissue from a symptomatic group, but that does not make it validated as a diagnostic biomarker. The study adds an important piece of information. It does not prove that every person with implants has elevated tinhome levels. It does not explain every symptom, and it does not establish that tinhome alone causes symptoms. Good science requires us to separate an association from diagnosis and a possible mechanism from proven causation. Join me this Thursday at 6 PM Central on Instagram, TikTok, YouTube, LinkedIn, Facebook X, Substack, or Rumble. Then bring your questions to the private Q&A inside Dr. Rob's Circle. That's our community. It's free to join. The link is in my bio. It's very simple to sign up. Send you a magic link. Look forward to seeing you this Thursday.
